Да ли су вам стандарди потребни у вашем послу?
Да
Не
Понекад
Не знам
Укупан број гласова: 7463

Пријавите се!
 


dnaSRPS EN 14476:2016/FprA2:2017

Фаза: 10.99 - Нови пројекат се прихвата
Почетак: 2017-01-01
Крај: 2017-03-01

Веза са међународним стандардима
Ovaj standard je identičan sa: EN 14476:2013+A1:2015/FprA2:2018 CEN/TC 216

Наслов на српском језику

Hemijska dezinfekciona sredstva i antiseptici — Kvantitativno ispitivanje suspenzije za vrednovanje virucidne aktivnosti u medicini — Metoda ispitivanja i zahtevi (faza 2/korak 1) -Izmena

Наслов на енглеском језику

Chemical disinfectants and antiseptics - Quantitative suspension test for the evaluation of virucidal activity in the medical area - Test method and requirements (Phase 2/Step 1)

Апстракт на српском језику

Нема информација.

Апстракт на енглеском језику

This European Standard specifies a test method and the minimum requirements for virucidal activity of chemical disinfectant and antiseptic products that form a homogeneous physically stable preparation when diluted with hard water or in the case of ready-to-use products, i. e, products that are not diluted when applied, with water. Products can only be tested at a concentration of 80 % (97 %, with a modified method for special cases) as some dilution is always produced by adding the test organisms and interfering substance. This European Standard applies to products that are used in the medical area in the fields of hygienic handrub, hygienic handwash, instrument disinfection by immersion, surface disinfection by wiping, spraying, flooding or other means and textile disinfection. This European Standard applies to areas and situations where disinfection is medically indicated. Such indications occur in patient care, for example: - in hospitals, in community medical facilities, and in dental institutions; - in clinics of schools, of kindergartens, and of nursing homes; and may occur in the workplace and in the home. It may also include services such as laundries and kitchens supplying products directly for the patients. NOTE 1 The method described is intended to determine the activity of commercial formulations or active substances under the conditions in which they are used. NOTE 2 This method corresponds to a phase 2, step 1 test. NOTE 3 EN 14885 specifies in detail the relationship of the various tests to one another and to "use recommendations".

Комисија за стандарде


ICS



Директиве